Dr. Sundeep Nutakki, Dr. V. Rama Mohana Rao, Dr G. Swarnalatha Devi


INTRODUCTION: Ageing is an inevitable process that converts young adults into older adults with deteriorating physiological fitness and
progressively increasing risks of illness and death. The ageing of the endocrine system is characterised by the progressive
loss of reserve capacity and impaired homeostatic regulation. These changes may not be clinically apparent under baseline conditions and the
presenting manifestations are often nonspecific or muted or atypical or subtle.
AIMS AND OBJECTIVES: 1. To estimate the prevalence of subclinical hypothyroidism in elderly patients attending Geriatric Outpatient
Department (Tertiary care centre).
MATERIALS AND METHODS: Outpatient setting in department of general medicine, ASRAM MEDICAL COLLEGE AND HOSPITAL
INCLUSION CRITERIA: All patients attending general medicine outpatient clinic during the above mentioned period (maximum of 50
EXCLUSION CRITERIA: 1. Patients with recent surgery, recent myocardial infarction and with recent acute illness followed by hospitalisation
in the past 6 months.
RESULTS: The prevalence of subclinical hypothyroidism is considerably high in this study (16.7%). The prevalence increases as the age
advances. The prevalence is more in females than in males.


CAD coronary artery disease, FT4 thyroxine ,TSH thyroid stimulating harmone

Full Text:



Cooper D: Subclinical hypothyroidism. N Engl J Med 345:260–265, 2001.

Canaris G et al: The Colorado thyroid disease prevalence study. Arch Intern Med 160:526–534, 2000.

Hak A et al: Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam study.Ann Intern Med 132:270–278, 2000.

Kahaly G: Cardiovascular and atherogenic aspects of subclinical hypothyroidism.Thyroid 10:665–679, 2000.

Mariotti S, Franceschi C, Cossarizza A, et al. The aging thyroid. Endocr Rev. 1995; 16: 686-715.

Turnbridge WMG, Evered DC, Hall R, et al. The spectrum of thyroid disease in a community: the Wickham survey. Clin Endocrinol (Oxf). 1977; 7: 481-493.

Hollowell J, Staehling NW, Flanders WD, et al. Serum TSH, T3 and thyroid antibodies in the United States population (1988 to 1994): National health and nutrion examination survey. J Clin Endocrinol Metab. 2992; 87: 489-499.

Parle JV, Franklyn JA, Cross JW, et al. Prevalence and follow-up of abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom. Clin Endocrinol (Oxf). 1991; 34: 77-83.

Biondi B, Palmieri EA, Lombardi G, et al. Effects of subclinical thyroid dysfunction on the heart. Ann Intern Med. 2002; 137: 904-914.

Gregersen PK, Lee HS, Batliwalla F, Begovich AB. PTPN22: setting thresholds for autoim-munity. Semin Immunol 18:214-23, 2006

Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA. 2004; 291: 228238.

Danese MD, Landenson PW, Meinert CL, Powe NR. Effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature. J Clin Endocrinol Metab. 2000; 85: 2993-3001.

Cooper DS. Subclinical thyroid disease: a clinician’s perspective. Ann Intern Med. 1998; 129: 135-137.

American College of Physicians. Screening for thyroid disease. Ann Intern Med 1998:129:141-143.

Ladenson PW, Singer PA, Ain KB, et al. American Thyroid Association guidelines for de-tection of thyroid dysfunction. Arch Intern Med. 2000; 160: 1573-1575.

US Preventive Services Task Force. Guide to Clinical Preventive Services. 2nd ed. Alexan-dria, VA: International Medical Publishing; 1996


  • There are currently no refbacks.